Bausch + Lomb Corp
NYSE:BLCO

Watchlist Manager
Bausch + Lomb Corp Logo
Bausch + Lomb Corp
NYSE:BLCO
Watchlist
Price: 17.65 USD -0.51% Market Closed
Market Cap: 6.2B USD
Have any thoughts about
Bausch + Lomb Corp?
Write Note
Section:
 

Relative Value

The Relative Value of one BLCO stock under the Base Case scenario is 41.22 USD. Compared to the current market price of 17.65 USD, Bausch + Lomb Corp is Undervalued by 57%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BLCO Relative Value
Base Case
41.22 USD
Undervaluation 57%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.4
P/S
P/S
Price to Sales
1.4
vs History
37
vs Industry
59
Median 3Y
1.4
Median 5Y
1.4
Industry
2.3
Forward
1.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
0
Median 3Y
-18.1
Median 5Y
-18.1
Industry
23
Forward
29.2
More Details
27.6
P/OCF
P/OCF
Price to OCF
27.6
vs History
40
vs Industry
3
Median 3Y
25.3
Median 5Y
25.3
Industry
14.3
More Details
74.9
P/FCFE
P/FCFE
Price to FCFE
74.9
vs History
3
vs Industry
40
Median 3Y
2.9
Median 5Y
2.9
Industry
20
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
3
vs Industry
66
Median 3Y
0.9
Median 5Y
0.9
Industry
2.2
More Details
2.3
EV/S
EV/S
Enterprise Value to Sales
2.3
vs History
21
vs Industry
45
Median 3Y
2.3
Median 5Y
2.3
Industry
2.4
Forward
2.2
More Details
3.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.7
vs History
25
vs Industry
52
Median 3Y
3.7
Median 5Y
3.7
Industry
5
More Details
16.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
16.7
vs History
6
vs Industry
21
Median 3Y
15.5
Median 5Y
15.5
Industry
12.9
Forward
12
More Details
55.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
55.9
vs History
3
vs Industry
8
Median 3Y
47.3
Median 5Y
47.3
Industry
17.4
Forward
16
More Details
47.2
EV/OCF
EV/OCF
Enterprise Value to OCF
47.2
vs History
40
vs Industry
2
Median 3Y
38.5
Median 5Y
38.5
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
11
Median 3Y
-60.2
Median 5Y
-60.2
Industry
18.2
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
3
vs Industry
65
Median 3Y
0.8
Median 5Y
0.8
Industry
1.9
More Details

Multiples Across Competitors

BLCO Competitors Multiples
Bausch + Lomb Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD 1.4 -17.3 16.7 55.9
JP
Hoya Corp
TSE:7741
6.8T JPY 8.3 34.8 22.9 27.6
CH
Alcon AG
SIX:ALC
37.8B CHF 4.3 36 17.7 34.3
DK
Coloplast A/S
CSE:COLO B
175.9B DKK 6.5 34.8 22.4 26.4
US
Align Technology Inc
NASDAQ:ALGN
16.3B USD 4.1 37 18.7 22.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
52.2B CNY 11.8 28.2 24.5 24.5
KR
HLB Inc
KOSDAQ:028300
10.1T KRW 194.6 -54.4 -83.7 -79
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.5B USD 4.4 15.3 10.5 11.9
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 2.6 37.1 266.5 465.5
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.2 46.6 23.2 38.1
CH
Ypsomed Holding AG
SIX:YPSN
4.7B CHF 7.6 62.9 30.4 57.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Bausch + Lomb Corp
NYSE:BLCO
Average EV/EBITDA: 45.4
16.7
22%
0.8
JP
Hoya Corp
TSE:7741
22.9
15%
1.5
CH
Alcon AG
SIX:ALC
17.7
10%
1.8
DK
Coloplast A/S
CSE:COLO B
22.4
11%
2
US
Align Technology Inc
NASDAQ:ALGN
18.7
15%
1.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.5
27%
0.9
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -83.7 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.5
11%
1
UK
ConvaTec Group PLC
LSE:CTEC
266.5
12%
22.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.2
22%
1.1
CH
Ypsomed Holding AG
SIX:YPSN
30.4
35%
0.9

See Also

Summary
BLCO intrinsic value, competitors valuation, and company profile.
DCF Valuation
BLCO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BLCO stock valuation using valuation multiples.
Wall Street Estimates
BLCO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BLCO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 214,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.